Want to join the conversation?
$TMO 2Q15 Call: Life Sciences Solutions Segment Q215 revenue grew to $1.13Bil, up 2% compared with revenue of $1.10Bil in the second quarter of 2014 & organic revenue grew 7%. Q2 adjusted operating income in Life Sciences Solutions Segment increased 8% & adjusted operating margin was 28.6%, up 150BP compared with 27.1% in the 2014 quarter.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.